ArticleClinical case reports2021
Lichen planus flare following COVID-19 vaccination: A case report.
Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 54 citations in OpenAlex.
- New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination.SAGE open medical case reports · 2024Article
- A Generalized Lichen Planus Following COVID-19 Vaccination: A Case Report.Annals of dermatology · 2023Article
- Review
- Lichen planus after COVID-19 infection and vaccination.Archives of dermatological research · 2023Review
- Article
- Comprehensive Insight into Lichen Planus Immunopathogenesis.International journal of molecular sciences · 2023Review
- Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185".Journal of cosmetic dermatology · 2023Article
- Suggested risk factor for oral lichen planus arising after mRNA COVID-19 vaccination.Clinical case reports · 2022Article
- New-onset vitiligo following COVID-19 disease.Skin health and disease · 2022Article
- A Case of New-Onset Lichen Planus after COVID-19 Vaccination.Dermatology and therapy · 2022Article
- Cutaneous reactions to COVID-19 vaccine at the dermatology primary care.Immunity, inflammation and disease · 2022Article
- COVID-19 vaccine-related new-onset lichen planus.Clinical case reports · 2022Article
- Article
- Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022Review
- New-Onset Lichen Planus Induced by the Pfizer COVID-19 Vaccine.Case reports in dermatological medicine · 2022Article
- Lichen planus flare following COVID-19 vaccination: A case report.Clinical case reports · 2021Article
- Lichen striatus after COVID-19.Clinics in dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report the third case of cutaneous lichen planus (LP) following COVID-19 BNT162b2 vaccination in a 59-year-old woman with previous LP. The reactivation of LP in patients with dormant LP suggests a possible vaccine-induced immune dysregulation. We suggest that the already described vaccine-induced upregulation of Th1 response may play a relevant role in LP reactivation, through an increase in inflammatory cytokines involved in the pathogenesis of LP. Interestingly, LP has already been associated with vaccinations and viral infections including COVID-19 disease. However, the exact mechanism underlying LP (re)activation after Pfizer-BiotNtech COVID-19 vaccination is still widely unknown and needs to be further investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.